非布司他治疗痛风的效果怎么样?
(Alias: Febuxostat) is a tablet and an anti-gout drug. Febuxostat has a significant inhibitory effect on both oxidized and reduced XOR, so its effect of reducing uric acid is more powerful and lasting. Therefore, this product can be used to treat chronic hyperuricemia in gout. What is the effect of febuxostat in treating gout?
The therapeutic effect of febuxostat in the treatment of gout:
To explore the clinical efficacy of febuxostat (alias: febuxostat) combined with loxoprofen sodium tablets in the treatment of gout associated with hyperuricemia.
A total of 72 patients with gout and hyperuricemia admitted to the hospital from January 2014 to January 2018 were selected and divided into an observation group (n=36) and a control group (n=36) based on the random number table method.
The control group was treated with febuxostat, and the observation group was treated with febuxostat + loxoprofen sodium tablets. Both groups were treated continuously for 12 weeks. During this period, high-purine diets were strictly prohibited, and the daily water intake was >2000ml. The clinical efficacy, pain scores, blood uric acid levels and quality of life scores of the two groups were compared before and after treatment, and the incidence of adverse reactions during treatment was statistically compared between the two groups.
Results The effective rate of the observation group was 77.78% (28/36), which was higher than the 55.56% (20/36) of the control group, P0.05). After treatment, the blood uric acid level and pain score of the observation group were lower than those of the control group (P0.05). After treatment, the quality of life scores of the observation group were higher than those of the control group (P0.05).
Conclusion: Febuxostat (alias: febuxostat) combined with loxoprofen sodium tablets has significant efficacy in the treatment of gout associated with hyperuricemia. It can effectively relieve pain, reduce blood uric acid levels, help improve patients' quality of life, and is highly safe.
Patients are reminded that because it is a drug that inhibits uric acid production, it cannot completely cure the problem of abnormal purine metabolism in the human body.
Recommended related hot articles: /newsDetail/74656.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)